Evidex
Evidex streamlines automated surveillance across diverse data sources, seamlessly integrating with a GVP IX compliant signal management platform. This innovative solution enhances safety data analysis by combining traditional and unstructured data, optimizing signaling algorithms, and enabling efficient validations. It empowers organizations to prioritize value-driven safety management while ensuring regulatory compliance.
Top Evidex Alternatives
StackScan
Find and compile website lists based on the technology stacks they use, covering 50,000+ technologies across 105 million domains.
ChemDraw
ChemDraw® solutions have been empowering chemists since 1985, transforming complex ideas into polished publications. With ChemOffice+ Cloud, users can efficiently manage and present their research, leveraging tools that streamline the creation of reports and presentations. This suite enhances communication by facilitating the organization and reuse of chemical data and structures.
Gritstone
Gritstone leverages its proprietary Gritstone EDGE™ platform to identify and analyze tumor-specific neoantigens through advanced machine learning. By integrating extensive data from diverse patient samples, it effectively pinpoints which mutations are transcribed and presented by HLA molecules, enhancing the development of targeted cancer immunotherapies.
ArgusLab
ArgusLab is a molecular modeling and drug design software designed for Windows, gaining popularity despite its age, with over 20,000 downloads. Freely licensed, it’s ideal for educators wishing to enhance their students' learning experience without redistribution concerns. Efforts are underway to expand its accessibility to iPad and cross-platform systems.
Kaleido
Kaleido pioneers the exploration of the human microbiome, a complex ecosystem of over 30 trillion microbes linked to various health disorders. By developing innovative therapeutic solutions that harness this intricate microbial community, Kaleido aims to transform patient care, addressing conditions like cardiovascular disease and diabetes with precision and insight.
Genomenon
Accelerating NGS variant interpretation, this drug discovery software enables rapid exploration of genomic literature, offering insights into over 26 million variants. Researchers can efficiently prioritize variants linked to diseases and therapies, leveraging a robust database and expert curation to streamline analysis and enhance confidence in identifying disease-causing variants, ultimately advancing precision medicine.
Aurora Drug Discovery
Leveraging advanced quantum mechanics and thermodynamics, Aurora Drug Discovery utilizes an innovative continuous water model to calculate ligand binding affinities. By incorporating entropy and electrostatic contributions directly into its algorithms, Aurora generates precise binding free energy values, enhancing the prediction of inhibition constants and improving drug discovery outcomes significantly.
BIOiSIM
A pioneering virtual drug development engine, BIOiSIM® streamlines drug discovery by identifying compounds likely to succeed in treating specific diseases. Built on extensive data across multiple species, it enhances translational accuracy and minimizes R&D waste, enabling faster pathways to clinical trials and ultimately improving patient outcomes with innovative therapies.
SILCS
SILCS is a cutting-edge drug discovery software that employs Site Identification by Ligand Competitive Saturation to produce 3D FragMaps, revealing interaction patterns of functional groups with target molecules. This platform enhances ligand optimization through dynamic insights into binding pockets, facilitating efficient drug design and rapid exploration of favorable interactions.
FCS Express
FCS Express™ seamlessly transforms raw flow cytometry data into clear, presentation-ready results with remarkable efficiency. Designed for researchers familiar with Microsoft Office™, it enhances user experience and reduces complexity. With real-time data linking and intuitive interfaces, it empowers clinical and academic labs to deliver accurate analyses effortlessly.
SpliceCore
SpliceCore leverages RNA sequencing data and advanced artificial intelligence to transform therapeutic development for splicing errors. With a unique database of over 5 million splicing errors, it rapidly identifies and validates potential drug targets. Scalable cloud computing enhances processing speed and efficiency, propelling innovative RNA therapeutics discovery forward.
DNAnexus Apollo
DNAnexus Apollo™ revolutionizes precision drug discovery by integrating multimodal data, analytics, and collaboration tools in a secure cloud platform. It enables scientists to seamlessly combine omics and clinical data, deploy bioinformatics pipelines, and leverage AI/ML algorithms, fostering a collaborative environment that accelerates insights and enhances data-driven research.
Eidogen-Sertanty Target Informatics Platform (TIP)
The Target Informatics Platform (TIP) revolutionizes structural informatics by allowing researchers to explore the druggable genome through a structural lens. It enhances the utilization of experimental protein structure data, shifting structure-based drug discovery into a high-throughput, data-rich domain, while effectively merging bioinformatics and cheminformatics insights to optimize the discovery pipeline.
Recursion
Leveraging proprietary biological, chemical, and real-world patient data, this advanced biotechnology company utilizes a supercomputer, BioHive-2, to scale up drug discovery. By producing over 1 trillion hiPSC-derived neuronal cells and employing CRISPR and advanced robotics, it decodes complex gene-compound relationships to revolutionize the pharmaceutical landscape.
VeraChem
VeraChem offers advanced computational chemistry software designed for precision in drug discovery. It features robust tools for predicting protein-ligand binding affinities, calculating accurate partial atomic charges, and employing the Tork algorithm for conformational searches. Additionally, it automates resonance form generation and detects molecular symmetries, enhancing research efficiency.
Atomwise
Harnessing the power of AI, this platform revolutionizes drug discovery by integrating machine learning with vast chemical libraries. Its innovative engine employs convolutional neural networks to efficiently explore trillions of compounds, increasing the probability of identifying effective small-molecule medicines. The focus remains on tackling challenging targets to enhance drug developers' success rates.
Company Information
- Company: Advera Health Analytics
- Country: United States
